HearPO and American Diabetes Association enter National Strategic Partnership

NewsGuard 100/100 Score

HearPO is proud to announce a National Strategic Partnership with the American Diabetes Association.  This National Strategic Partnership will provide additional resources and avenues to educate people with diabetes, medical practitioners and the general public about the connection between diabetes and hearing loss.

HearPO, along with its sister companies, Miracle-Ear, Sonus, and the Elite Hearing Network, is the largest distributor of hearing aids and hearing services in the world. Together the American Diabetes Association and HearPO are working to locate and treat diabetic patients who, for whatever reason, have not been diagnosed or treated for existing hearing loss.

"We are pleased HearPO is joining with us to spread the word that there is a direct correlation between diabetes and hearing loss," says Nash M. Childs, PE, Chair of the Board, American Diabetes Association. "More specifically, we'd like to educate older adults with diabetes, as this population faces many issues in managing their disease and through this relationship we'll be able to provide additional tools and resources."

Closing the Gap

Patients with diabetes are more than twice as likely as those without the disease to have hearing loss, according to a recent National Institutes of Health (NIH) study.  More than 34 million Americans are affected by hearing loss, which can be fully corrected in 95% of all cases. Many of those affected are people with diabetes. HearPO and the American Diabetes Association are collaborating using several outreach methods to encourage people to be tested and treated where necessary.

"We are thrilled to be a National Strategic Partner of the American Diabetes Association, and embrace the opportunity to significantly improve the lives of so many people with diabetes," says Michele Fusco, Senior Vice President of Medical Business Operations. "HearPO's national awareness campaign will allow us to focus the efforts of our Sonus and HearPO consumer brands to proactively educate and assist an often unrecognized and underserved segment of the population. Together we will make significant strides toward literally transforming the quality of life for millions of Americans."

Education and Treatment

HearPO and the Association have outlined the following methods to better educate and target diabetic patients suffering from untreated hearing loss:

  • HearPO will offer testing sites and educational seminars in conjunction with the 2011 American Diabetes Association EXPO season which draws roughly 70,000 participants, particularly those living with diabetes.
  • "Diabetes & Older Americans" Educational Booklet (Available Spring 2011)
    • The booklet will focus on the broad health needs of older adults diagnosed with diabetes. This educational resource will also spread awareness about the incidence of hearing loss among Americans with diabetes.
  • Diabetes.org
    • This Association website, with 48,000 unique visitors daily, will now feature expanded content about hearing loss as a complication of diabetes. One of the featured topics will include hearing impairment and strategies for dealing with it. Specifically, the Association will provide a link from the "Treatment & Care" page to the newly added information related to hearing impairment.
    • Users on the Association site will also be linked to the HearPO's locator function to learn where they can get a hearing screening and take part in HearPO discount programs.
    • The Association will offer visitors on the site the opportunity to download a PDF version of the "Diabetes & Older Americans" Educational Booklet, or the chance to request a copy by calling 1-800-DIABETES.

SOURCE HearPO

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can monitoring and encouraging physical activity through phone-based apps improve glycemic control and weight loss in type 2 diabetes patients?